137 related articles for article (PubMed ID: 7701049)
1. Pharmacokinetics and bioavailability of benperidol in schizophrenic patients after intravenous and two different kinds of oral application.
Seiler W; Wetzel H; Hillert A; Schöllnhammer G; Langer M; Barlage U; Hiemke C
Psychopharmacology (Berl); 1994 Dec; 116(4):457-63. PubMed ID: 7701049
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of benperidol, prolactin, and homovanillic acid after intravenous versus two different kinds of oral application of the neuroleptic in schizophrenic patients.
Seiler W; Wetzel H; Hillert A; Schöllnhammer G; Benkert O; Hiemke C
Exp Clin Endocrinol; 1994; 102(4):326-33. PubMed ID: 7813605
[TBL] [Abstract][Full Text] [Related]
3. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of benperidol in volunteers after oral administration.
Furlanut M; Benetello P; Perosa A; Colombo G; Gallo F; Forgione A
Int J Clin Pharmacol Res; 1988; 8(1):13-6. PubMed ID: 3366499
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of haloperidol and reduced haloperidol in Chinese schizophrenic patients after intravenous and oral administration of haloperidol.
Chang WH; Lam YW; Jann MW; Chen H
Psychopharmacology (Berl); 1992; 106(4):517-22. PubMed ID: 1579624
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations.
Göhler K; Brett M; Smit JW; Rengelshausen J; Terlinden R
Int J Clin Pharmacol Ther; 2013 Apr; 51(4):338-48. PubMed ID: 23357834
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects.
Rochdi M; Sabouraud A; Girre C; Venet R; Scherrmann JM
Eur J Clin Pharmacol; 1994; 46(4):351-4. PubMed ID: 7957521
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and bioavailability of sulfadiazine and trimethoprim following intravenous, intramuscular and oral administration in ostriches (Struthio camelus).
Abu-Basha EA; Gehring R; Hantash TM; Al-Shunnaq AF; Idkaidek NM
J Vet Pharmacol Ther; 2009 Jun; 32(3):258-63. PubMed ID: 19646090
[TBL] [Abstract][Full Text] [Related]
11. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bioavailability of doxycycline in ostriches (Struthio camelus) at two different dose rates.
Abu-Basha EA; Idkaidek NM; Hantash TM
J Vet Sci; 2006 Dec; 7(4):327-32. PubMed ID: 17106222
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine.
Olsson B; Johansson M; Gabrielsson J; Bolme P
Eur J Clin Pharmacol; 1988; 34(1):77-82. PubMed ID: 3360052
[TBL] [Abstract][Full Text] [Related]
14. Determination of benperidol and its reduced metabolite in human plasma by high-performance liquid chromatography and electrochemical detection.
Süss S; Seiler W; Hiemke C; Schöllnhammer G; Wetzel H; Hillert A
J Chromatogr; 1991 Apr; 565(1-2):363-73. PubMed ID: 1874880
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.
Bagli M; Rao ML; Höflich G; Kasper S; Langer M; Barlage U; Beneke M; Süverkrüp R; Möller HJ
Arzneimittelforschung; 1996 Mar; 46(3):247-50. PubMed ID: 8901143
[TBL] [Abstract][Full Text] [Related]
16. Elimination half-life and bioavailability of haloperidol in schizophrenic patients.
Magliozzi JR; Hollister LE
J Clin Psychiatry; 1985 Jan; 46(1):20-1. PubMed ID: 3965439
[TBL] [Abstract][Full Text] [Related]
17. Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats.
King JN; Jung M; Maurer MP; Schmid VB; Seewald W; Lees P
Am J Vet Res; 2013 Mar; 74(3):465-72. PubMed ID: 23438125
[TBL] [Abstract][Full Text] [Related]
18. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs.
Kendall J; Papich MG
Am J Vet Res; 2015 May; 76(5):454-9. PubMed ID: 25909378
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and bioavailability of oral ergometrine in male volunteers.
de Groot AN; Vree TB; Hekster YA; van den Biggelaar-Martea M; van Dongen PW; van Roosmalen J
Biopharm Drug Dispos; 1994 Jan; 15(1):65-73. PubMed ID: 8161717
[TBL] [Abstract][Full Text] [Related]
20. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
